Iris Ciba

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Correction: Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS.

Correction: Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS.

Journal: Cardiovascular diabetology

Published: November 02, 2025

The GLP-1 Agonist Exenatide Is Associated with Improved Adherence to Health Behavior and Lifestyle Treatment in Adolescents with Obesity: A Randomized Controlled Trial.

The GLP-1 Agonist Exenatide Is Associated with Improved Adherence to Health Behavior and Lifestyle Treatment in Adolescents with Obesity: A Randomized Controlled Trial.

Journal: Obesity facts

Published: October 29, 2025

Evaluation of BMI Growth Charts for Children Living with Severe Obesity.

Evaluation of BMI Growth Charts for Children Living with Severe Obesity.

Journal: Childhood obesity (Print)

Published: June 26, 2025

Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS.

Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS.

Journal: Cardiovascular diabetology

Published: April 14, 2025

Validation of Fat Mass Metrics in Pediatric Obesity.

Validation of Fat Mass Metrics in Pediatric Obesity.

Journal: Annals of nutrition & metabolism

Published: July 04, 2024

Obesity-related subclinical hypothyroidism in childhood: Elevated triglycerides but not basal metabolic rate.

Obesity-related subclinical hypothyroidism in childhood: Elevated triglycerides but not basal metabolic rate.

Journal: Pediatric research

Published: May 08, 2024

Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control.

Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control.

Journal: Frontiers in endocrinology

Published: September 12, 2023

Metformin Can Attenuate Beta-Cell Hypersecretion-Implications for Treatment of Children with Obesity.

Metformin Can Attenuate Beta-Cell Hypersecretion-Implications for Treatment of Children with Obesity.

Journal: Metabolites

Published: July 06, 2023

Studies in children with obesity in two European treatment centres show a high prevalence of impaired glucose metabolism in the Swedish cohort.

Studies in children with obesity in two European treatment centres show a high prevalence of impaired glucose metabolism in the Swedish cohort.

Journal: Acta paediatrica (Oslo, Norway : 1992)

Published: January 30, 2023

Screening for Inflammatory Markers Identifies IL-18Rα as a Potential Link between Exenatide and Its Anti-Inflammatory Effect: New Results from the Combat-JUDO Randomized Controlled Trial.

Screening for Inflammatory Markers Identifies IL-18Rα as a Potential Link between Exenatide and Its Anti-Inflammatory Effect: New Results from the Combat-JUDO Randomized Controlled Trial.

Journal: Annals of nutrition & metabolism

Published: December 08, 2022

Association between alanine aminotransferase as surrogate of fatty liver disease and physical activity and sedentary time in adolescents with obesity.

Association between alanine aminotransferase as surrogate of fatty liver disease and physical activity and sedentary time in adolescents with obesity.

Journal: European journal of pediatrics

Published: February 17, 2022

Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease.

Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease.

Journal: Frontiers in endocrinology

Published: December 06, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026